Among the different cancer subtypes, Jadaliha et al. found that MALAT-1 expression was consistently higher in ER-positive patients than in those with the triple-negative breast cancer (TNBC) subtype [24]. This evidence concerns the gene MALAT1 and triple-negative breast carcinoma.